Výsledky vyhledávání - "Chintan V. Pandya"

Akademický článek

Determination of flavonoids, phenolic acid and polyalcohol in Butea monosperma and Hedychium coronarium by semi-preparative HPLC Photo Diode Array (PDA) Detector

Autor: Jignasu P. Mehta, Chintan V. Pandya, Pravin H. Parmar, Sohil H. Vadia, Balubhai A. Golakiya

Publikováno v: Arabian Journal of Chemistry, Vol 7, Iss 6, Pp 1110-1115 (2014)

The semi preparative HPLC method with PDA Detector was proposed for the determination of one phenolic acid, three flavonoids and one polyalcohol from Butea monosperma and Hedychium coronarium in gradient elution system. The influence of composition o

Externí odkaz: https://doaj.org/article/0945b6a243244b449695f0c0aa704809

Zobrazit plný text záznamu

Novel UHPLC DAD Method for Simultaneous determination of Vildagliptin and Metformin in Bulk and its Tablet formulation

Autor: Aditee C Pandya, Chintan V Pandya, Viralkumar Patel, Zalak Patel, Dharmesh Patel

Publikováno v: Research Journal of Pharmacy and Technology. :4143-4150

A robust and rapid reversed-phase UHPLC method for routine determination of vildagliptin (VILDA) and metformin (MET) was developed and validated with DAD detection (207 nm). Chromatographic analysis was carried out with isocratic separation by C18 co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::72d45f565227fed8a5224aa4d0aac7c3
https://doi.org/10.52711/0974-360x.2021.00717

Zobrazit plný text záznamu

Validation of Novel Analytical RP-HPLC Method for determination of Formoterol Fumarate and Budesonide in Inhalation Suspension Pharmaceutical Dosage Form

Autor: Aditee C Pandya, Ravindra K Kotak, Chintan V Pandya

Publikováno v: Research Journal of Pharmacy and Technology. :4383-4390

Formoterol Fumarate and Budesonide inhalation suspension is prescribed for treatment of Asthmatic patient. Formoterol Fumarate is anti-asthmatic drug (Bronchodilator) and Budesonide is Anti Inflammatory Drug (Glucocortico steroid) drug. A bronchodila

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fd88969e0bdd820be260dbe477d941f5
https://doi.org/10.52711/0974-360x.2021.00761

Zobrazit plný text záznamu

Determination of Spray Pattern and Plume Geometry of Combined Budesonide and Formoterol Fumarate pressurized Metered Dose Inhalation Aerosol

Autor: Ravindra K Kotak, Avnish Rajput, Brajesh Kumar Thakur, Chintan V Pandya, Aditee C Pandya

Publikováno v: International Journal of Pharmaceutical Sciences and Drug Research. :614-620

Budesonide and formoterol fumarate pressurized metered-dose inhaler (pMDI) is combined aerosol dosage form. The label claim of this combined dosage form is 100 mcg of Budesonide and 6 mcg of Formoterol Fumarate per actuation. It is prescribed for the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7d6c15bc5c338130649bd8fc4ade5a13
https://doi.org/10.25004/ijpsdr.2020.120605

Zobrazit plný text záznamu

Validation of In-vitro Deposition of Emitted Dose Method for Simultaneous Estimation of Formoterol Fumarate and Glycopyrrolate in combined Dry Powder Inhaler Aerosol Pharmaceutical Dosage Form

Autor: Aditee C Pandya, Chintan V Pandya, Ravindra K Kotak

Publikováno v: International Journal of Pharmaceutical Sciences and Drug Research. :501-508

Formoterol Fumarate and Glycopyrrolate Dry powder inhaler is combined aerosol dosage form. The label claim of this combined dosage form is 25 mcg of Glycopyrrolate and 6 mcg of Formoterol Fumarate per respicap. It is prescribed for treatment of Asthm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ae759544aeff5f593aaff1f2634c9805
https://doi.org/10.25004/ijpsdr.2020.120511

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání